Literature DB >> 35344032

PD-LI promotes rear retraction during persistent cell migration by altering integrin β4 dynamics.

Mengdie Wang1, Choua Xiong1, Arthur M Mercurio1.   

Abstract

Although the immune checkpoint function of PD-L1 has dominated its study, we report that PD-L1 has an unanticipated intrinsic function in promoting the dynamics of persistent cell migration. PD-L1 concentrates at the rear of migrating carcinoma cells where it facilitates retraction, resulting in the formation of PD-L1-containing retraction fibers and migrasomes. PD-L1 promotes retraction by interacting with and localizing the β4 integrin to the rear enabling this integrin to stimulate contractility. This mechanism involves the ability of PD-L1 to maintain cell polarity and lower membrane tension at the cell rear compared with the leading edge that promotes the localized interaction of PD-L1 and the β4 integrin. This interaction enables the β4 integrin to engage the actin cytoskeleton and promote RhoA-mediated contractility. The implications of these findings with respect to cell-autonomous functions of PD-L1 and cancer biology are significant.
© 2022 Wang et al.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35344032      PMCID: PMC8965106          DOI: 10.1083/jcb.202108083

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  60 in total

1.  Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway.

Authors:  Shaojia Wang; Jiajia Li; Jie Xie; Fei Liu; Yachen Duan; Yong Wu; Shenglin Huang; Xianghuo He; Ziliang Wang; Xiaohua Wu
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

2.  Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth.

Authors:  Yi Yang; Chia-Wei Li; Li-Chuan Chan; Yongkun Wei; Jung-Mao Hsu; Weiya Xia; Jong-Ho Cha; Junwei Hou; Jennifer L Hsu; Linlin Sun; Mien-Chie Hung
Journal:  Cell Res       Date:  2018-06-29       Impact factor: 25.617

3.  Membrane tension maintains cell polarity by confining signals to the leading edge during neutrophil migration.

Authors:  Andrew R Houk; Alexandra Jilkine; Cecile O Mejean; Rostislav Boltyanskiy; Eric R Dufresne; Sigurd B Angenent; Steven J Altschuler; Lani F Wu; Orion D Weiner
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

4.  Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium.

Authors:  R Meili; C Ellsworth; S Lee; T B Reddy; H Ma; R A Firtel
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 5.  Random versus directionally persistent cell migration.

Authors:  Ryan J Petrie; Andrew D Doyle; Kenneth M Yamada
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07-15       Impact factor: 94.444

6.  Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site.

Authors:  R Gary; A Bretscher
Journal:  Mol Biol Cell       Date:  1995-08       Impact factor: 4.138

7.  The role of lipid rafts in cancer cell adhesion and migration.

Authors:  Toshiyuki Murai
Journal:  Int J Cell Biol       Date:  2011-12-29

8.  Pairing of integrins with ECM proteins determines migrasome formation.

Authors:  Danni Wu; Yue Xu; Tianlun Ding; Yan Zu; Chun Yang; Li Yu
Journal:  Cell Res       Date:  2017-08-22       Impact factor: 25.617

Review 9.  The plasma membrane as a mechanochemical transducer.

Authors:  Anabel-Lise Le Roux; Xarxa Quiroga; Nikhil Walani; Marino Arroyo; Pere Roca-Cusachs
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-01       Impact factor: 6.237

10.  Compartmentalization of integrin alpha6beta4 signaling in lipid rafts.

Authors:  Laurent Gagnoux-Palacios; Michael Dans; Wouter van't Hof; Agnese Mariotti; Angela Pepe; Guerrino Meneguzzi; Marilyn D Resh; Filippo G Giancotti
Journal:  J Cell Biol       Date:  2003-09-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.